Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34.... 34 Next >

Ethicon-Endo Surgery Completes Acquisition of SterilMed

November 04, 2011

FDA Approves XARELTO® (Rivaroxaban) To Reduce The Risk Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation

November 04, 2011

Steering Drivers In The Right Direction, “Healthy Vision™ With Dr. Val Jones” Radio Show Offers Information, Advice About Driving In The Dark

November 01, 2011

Supplemental New Drug Application Submitted To FDA For NUCYNTA® ER (Tapentadol) Extended-Release Tablets For Diabetic Peripheral Neuropathic Pain

October 31, 2011

STELARA® (Ustekinumab) Is Effective, Well-Tolerated And Improves Quality Of Life In Patients With Moderate To Severe Plaque Psoriasis Inadequately Responsive To Methotrexate

October 21, 2011

FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment

October 21, 2011

< Prev | | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34.... 34 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.